Brilinta Market size was valued at USD 1.5 billion in 2025 & is estimated to reach USD 2.8 billion by 2034, exhibiting a CAGR of 7.8%from 2026-2034 The Brilinta Market was valued at USD 1,506.2 million in 2024 and is projected to reach USD 2,329.1 million by 2032, growing at a CAGR of 5.6% during the forecast period. Worldwide Brilinta Market 2026 Global Brilinta Market Size, Share & Industry Analysis, By Dosage Strength (90mg Tablets, 60mg Tablets), By Indication (Acute Coronary Syndrome, Coronary Artery Disease), and Regional Forecast 2026-2032. The research and development of new pharmaceutical compound containing Brilinta molecule and increasing awareness of benefits of Brilinta may drive the global Brilinta molecule. The North America market for Brilinta is expected to be the largest shareholding market during the forecast period. Europe second highest as per market share. To focus on the key Brilinta Market manufacturers, defining, describing, and analyzing their sales volume, value, market share, market competition landscape, SWOT analysis, and development plans. To analyze the Brilinta Market with respect to individual growth trends, prospects, and their contribution to the total market. Annual Sales of Brilinta reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies. The Brilinta market was valued at $6.8 billion in 2025 and is projected to reach $11.2 billion by 2034, growing at 5.8% CAGR. Global analysis of antiplatelet therapy market trends. Brilinta Market Size, Share, Growth, and Industry Analysis, By Type (90 mg Tablet, 60 mg Tablet), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, ), Regional Insights and Forecast to 2035 Brilinta Market Insights The global Brilinta market size was valued at USD 1.85 billion in 2025. The market is projected to grow from USD 1.98 billion in 2026 to USD 3.42 billion by 2034, exhibiting a CAGR of 7.1% during the forecast period. Brilinta, the trade name for ticagrelor, is an antiplatelet medication developed by AstraZeneca and primarily used to prevent cardiovascular events such … Report Snapshot The global Brilinta (ticagrelor) market was valued at $4.2 billion in 2025 and is projected to reach $7.8 billion by 2033, expanding at a compound annual growth rate (CAGR) of 7.9%. Brilinta is a P2Y12 platelet inhibitor used to reduce thrombotic events in patients with acute coronary syndrome and stable ischemic heart disease. North America commands 42% market share, driven by … The Brilinta Market Analysis market report covers financials, market share, SWOTs, and responses to Tariffs, while providing global, regional, and country-level forecasts supported by value chain, patent analysis, and a competitive matrix serving as a key resource for stakeholders and investors. The Brilinta market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. BRILINTA is a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. BRILINTA also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS. (1.1 … BRILINTA is indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Brilinta market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031. Brilinta Market Overview The global Brilinta market size was valued at USD 2248.57 million in 2026 and is expected to reach USD 2440.82 million in 2027, further expanding to USD 4706.23 million by 2035, growing at a CAGR of 8.55% during the forecast period. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Brilinta market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Brilinta Market Overview The global Brilinta Market size is projected to grow from USD 2248.57 million in 2026 to USD 2440.69 million in 2027, reaching USD 4705.16 million by 2035, expanding at a CAGR of 8.55% during the forecast period. The global Brilinta market size is expected to reach $ million by 2031, rising at a market growth of %CAGR during the forecast period (2025-2031). This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Brilinta sales, projected growth trends, production technology, application and end-user industry. Global Brilinta Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape) This global Brilinta market research report provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative … AstraZeneca said on Tuesday Brilinta did not show a benefit over older blood thinner clopidogrel in treating peripheral artery disease (PAD) in a large-scale clinical trial. PAD usually affects … The Brilinta Market report provides a holistic evaluation of the market for the forecast period (2017-2026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. What is the estimated North America Brilinta Market size and CAGR from 2026 to 2033? North America Brilinta Market size was valued at USD 0.6 Billion in 2024 and is projected to reach USD 0. Brilinta Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026 The Brilinta Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter's Five Forces analyses of the Brilinta Market, which highlight the strengths, weaknesses, opportunities, and commination of key … Brilinta is the trade name of ticagrelor, is a platelet aggregation inhibitor produced by AstraZeneca. It's a blow to AZ, particularly after Brilinta had begun to gather speed. Stepped-up marketing and one new indication helped boost sales by 48% for the first half of this year. This report focuses on the Brilinta sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Brilinta market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. Brilinta Market Brilinta Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027 The Brilinta Market Market is segmented by Product Type (90 mg Tablet , 60 mg Tablet ) By Application (Hospital Pharmacies , Retail Pharmacies , Online Pharmacies ) By Company (Astrazeneca ) By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). Extent Research provides information about the sales and revenue during the historic and forecasted period of 2017 to … Key non-oncology meds, such as blood thinner Brilinta and SGLT2 diabetes product Farxiga, beat (PDF) consensus and posted growth of 30% or more, racking up sales of $284 million and $285 million … The Brilinta market size, estimations, and forecasts are provided in terms of sales volume (k pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brilinta market comprehensively. The Global Brilinta Market exhibits dynamic growth patterns across global regions, shaped by economic conditions, regulatory frameworks, technological adoption, and evolving consumer preferences. The Brilinta market size, estimations, and forecasts are provided in terms of sales volume (k pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brilinta market comprehensively. The Brilinta market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Germany Brilinta Market Size and Forecast 2026-2033 Germany Brilinta Market size was valued at USD 0.15 Billion in 2024 and is projected to reach USD 0. The Brilinta market expands as regulatory approvals, clinical advancements, and rising cardiovascular disease (CVD) prevalence drive adoption across regions. In North America, an aging population fuels demand for effective antiplatelet therapies, with the U.S. Census Bureau projecting about 20% of Americans over 65 by 2030. Obesity and diabetes amplify this need, while healthcare providers … The Global Brilinta Market study contains information on the global industry, as well as user data and numbers. The Global Market is examined in depth in this research report, including raw material suppliers, industry chain structures, and manufacturing. The Brilinta Sales market investigates the market's most important segments. This insightful analysis includes historical data as well as a …
